Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Neurocrine Biosciences Revenue 2006-2018 | NBIX

Neurocrine Biosciences annual/quarterly revenue history and growth rate from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Neurocrine Biosciences revenue for the quarter ending December 31, 2018 was $0.131B, a 39.12% increase year-over-year.
  • Neurocrine Biosciences revenue for the twelve months ending December 31, 2018 was $0.451B, a 179.19% increase year-over-year.
  • Neurocrine Biosciences annual revenue for 2018 was $0.451B, a 179.19% increase from 2017.
  • Neurocrine Biosciences annual revenue for 2017 was $0.162B, a 977.51% increase from 2016.
  • Neurocrine Biosciences annual revenue for 2016 was $0.015B, a 24.12% decline from 2015.
Neurocrine Biosciences Annual Revenue
(Millions of US $)
2018 $451
2017 $162
2016 $15
2015 $20
2014 $0
2013 $3
2012 $53
2011 $77
2010 $34
2009 $3
2008 $4
2007 $1
2006 $39
2005 $124
Neurocrine Biosciences Quarterly Revenue
(Millions of US $)
Q4 2018 $131
Q3 2018 $152
Q2 2018 $97
Q1 2018 $71
Q4 2017 $95
Q3 2017 $61
Q2 2017 $6
Q1 2017 $0
Q4 2016 $0
Q3 2016 $0
Q2 2016 $0
Q1 2016 $15
Q4 2015 $0
Q3 2015 $0
Q2 2015 $0
Q1 2015 $20
Q4 2014 $0
Q3 2014 $0
Q2 2014 $0
Q1 2014 $0
Q4 2013 $1
Q3 2013 $1
Q2 2013 $1
Q1 2013 $1
Q4 2012 $22
Q3 2012 $9
Q2 2012 $11
Q1 2012 $11
Q4 2011 $11
Q3 2011 $42
Q2 2011 $12
Q1 2011 $13
Q4 2010 $14
Q3 2010 $14
Q2 2010 $5
Q1 2010 $1
Q4 2009 $1
Q3 2009 $1
Q2 2009 $1
Q1 2009 $1
Q4 2008 $1
Q3 2008 $1
Q2 2008 $1
Q1 2008 $2
Q4 2007 $1
Q3 2007 $1
Q2 2007 $0
Q1 2007 $0
Q4 2006 $9
Q3 2006 $1
Q2 2006 $9
Q1 2006 $19
Q4 2005 $14
Q3 2005 $65
Q2 2005 $33
Q1 2005 $12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.664B $0.451B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.398B 30.86
Takeda Pharmaceutical (TAK) Japan $33.153B 12.27
Grifols (GRFS) Spain $13.201B 16.00
Ionis Pharmaceuticals (IONS) United States $10.870B 34.75
Jazz Pharmaceuticals (JAZZ) Ireland $7.800B 11.17
Sage Therapeutics (SAGE) United States $7.450B 0.00
Tilray (TLRY) United States $6.754B 0.00
Nektar Therapeutics (NKTR) United States $6.186B 9.87
Catalent (CTLT) United States $6.146B 25.73
United Therapeutics (UTHR) United States $5.149B 8.76
FibroGen (FGEN) United States $4.834B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.238B 13.64
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.164B 0.00
Portola Pharmaceuticals (PTLA) United States $2.224B 0.00
Zogenix (ZGNX) United States $2.190B 0.00
USANA Health Sciences (USNA) United States $2.146B 18.01
Aerie Pharmaceuticals (AERI) United States $2.135B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.134B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
PTC Therapeutics (PTCT) United States $2.103B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.968B 24.51
Endo (ENDP) Ireland $1.894B 2.92
Heron Therapeutics (HRTX) United States $1.853B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.754B 0.00
Xencor (XNCR) United States $1.688B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.592B 137.93
Corcept Therapeutics (CORT) United States $1.396B 20.28
Esperion Therapeutics (ESPR) United States $1.338B 0.00
TherapeuticsMD (TXMD) United States $1.317B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.276B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.108B 0.00
Tricida (TCDA) United States $1.047B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.888B 0.00
Radius Health (RDUS) United States $0.854B 0.00
Odonate Therapeutics (ODT) United States $0.635B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.602B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.573B 0.00
Collegium Pharmaceutical (COLL) United States $0.566B 0.00
Forty Seven (FTSV) United States $0.552B 0.00
GlycoMimetics (GLYC) United States $0.522B 0.00
ChemoCentryx (CCXI) United States $0.515B 0.00
ArQule (ARQL) United States $0.510B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.504B 29.73
Siga Technologies (SIGA) United States $0.503B 0.00
KalVista Pharmaceuticals (KALV) United States $0.499B 0.00
Akebia Therapeutics (AKBA) United States $0.466B 0.00
Flexion Therapeutics (FLXN) United States $0.456B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.431B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.405B 0.00
TCR2 THERAPTCS (TCRR) United States $0.402B 0.00
ImmunoGen (IMGN) United States $0.396B 0.00
Concert Pharmaceuticals (CNCE) United States $0.388B 0.00
OptiNose (OPTN) United States $0.376B 0.00
Translate Bio (TBIO) United States $0.375B 0.00
Aptorum Group (APM) China $0.373B 0.00
Majesco Entertainment (PTE) United States $0.335B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.332B 0.00
Minerva Neurosciences (NERV) United States $0.322B 0.00
Lannett Co Inc (LCI) United States $0.322B 2.99
CASI Pharmaceuticals (CASI) United States $0.310B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.306B 0.00
HARPOON THERAPT (HARP) United States $0.288B 0.00
Dermira (DERM) United States $0.288B 0.00
Karyopharm Therapeutics (KPTI) United States $0.287B 0.00
Mast Therapeutics (SVRA) United States $0.285B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.261B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.259B 9.60
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.250B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.244B 0.00
Tyme Technologies (TYME) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.232B 0.00
Aclaris Therapeutics (ACRS) United States $0.230B 0.00
Jounce Therapeutics (JNCE) United States $0.227B 0.00
Aldeyra Therapeutics (ALDX) United States $0.219B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
ElectroCore (ECOR) United States $0.215B 0.00
Galectin Therapeutics (GALT) United States $0.214B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.213B 0.00
Molecular Templates (MTEM) United States $0.209B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.207B 0.00
IMV INC (IMV) Canada $0.205B 0.00
Recro Pharma (REPH) United States $0.203B 0.00
Nature's Sunshine Products (NATR) United States $0.196B 203.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Redhill Biopharma (RDHL) Israel $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.179B 0.00
Ocular Therapeutix (OCUL) United States $0.173B 0.00
Aquestive Therapeutics (AQST) United States $0.162B 0.00
Neon Therapeutics (NTGN) United States $0.159B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.155B 0.00
Cardiome Pharma (CORV) Canada $0.150B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.144B 0.00
China SXT Pharmaceuticals (SXTC) China $0.142B 0.00
MediWound (MDWD) Israel $0.141B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.135B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.128B 0.00
DURECT (DRRX) United States $0.121B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
Adherex Technologies (FENC) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.113B 0.00
Zafgen (ZFGN) United States $0.112B 0.00
Infinity Pharmaceuticals (INFI) United States $0.102B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.092B 0.00
Natural Alternatives (NAII) United States $0.088B 8.63
Cumberland Pharmaceuticals (CPIX) United States $0.087B 0.00
Otonomy (OTIC) United States $0.086B 0.00
Genocea Biosciences (GNCA) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Iterum Therapeutics (ITRM) Ireland $0.076B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.075B 0.00
Avenue Therapeutics (ATXI) United States $0.062B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.062B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Capnia (SLNO) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.056B 0.00
KemPharm (KMPH) United States $0.054B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.045B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
Achaogen (AKAO) United States $0.036B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.035B 0.00
NOVAN INC (NOVN) United States $0.030B 0.00
ContraFect (CFRX) United States $0.029B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
ESSA Pharma (EPIX) Canada $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.022B 0.00
Pain Therapeutics (PTIE) United States $0.022B 0.00
Xenetic Biosciences (XBIO) United States $0.021B 0.00
Achieve Life Sciences (ACHV) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Shineco (TYHT) China $0.015B 2.60
Auris Medical Holding AG (EARS) Switzerland $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
VAXART, INC (VXRT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Intellipharmaceutics (IPCI) Canada $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00